Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 1/20 | 0.69 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.68 |
| ▸ | PTH1R | Q03431 | 4/20 | 0.67 |
| ▸ | GLP1R | P43220 | 5/20 | 0.67 |
| ▸ | CCKBR | P32239 | 1/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.66 |
| ▸ | ECE1 | P42892 | 1/20 | 0.65 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.65 |
| ▸ | IL23R | Q5VWK5 | 3/20 | 0.64 |
| ▸ | NPY2R | P49146 | 2/20 | 0.64 |
| ▸ | GHSR | Q92847 | 2/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30744286 | 0.97 | NR3C1 (0.71) | GRPRNR3C1PTH1RGLP1RCCKBR | |
| SCHEMBL30148541 | 0.95 | NR3C1 (0.74) | NR3C1PTH1RGLP1RCCKBRRXFP1 | |
| SCHEMBL29412274 | 0.91 | GLP1R (0.73) | GRPRNR3C1PTH1RGLP1RCCKBR | |
| SCHEMBL29395456 | 0.91 | GLP1R (0.78) | NR3C1PTH1RGLP1RCCKBRECE1 | |
| SCHEMBL29357856 | 0.91 | GLP1R (0.77) | NR3C1PTH1RGLP1RCCKBRECE1 | |
| SCHEMBL30411571 | 0.91 | PTH1R (0.77) | GRPRNR3C1PTH1RGLP1RCCKBR | |
| SCHEMBL30683162 | 0.90 | GLP1R (0.81) | NR3C1PTH1RGLP1RCCKBRECE1 | |
| SCHEMBL31396476 | 0.90 | PTH1R (0.74) | NR3C1PTH1RGLP1RCCKBRECE1 | |
| SCHEMBL29540128 | 0.89 | GLP1R (0.79) | NR3C1PTH1RGLP1RCCKBRRXFP1 | |
| SCHEMBL29664425 | 0.89 | GLP1R (0.72) | NR3C1PTH1RGLP1RCCKBRECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-PP36692-P2 | Clematis plant named ‘DP136’ | EARLY MORNING LLC (US) | 2025-05-20 | — | — | US | claimed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-PP36692-P2 | Clematis plant named ‘DP136’ | EARLY MORNING LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-PP36692-P2 | Clematis plant named ‘DP136’ | EARLY MORNING LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-11891457-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891457-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | GRPR 6/4885NR3C1 4084/4885PTH1R 89/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | GRPR 6/4885NR3C1 4084/4885PTH1R 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.